Concepedia

Byron DeLaBarre

BD

Statistics

Publications

18

Citations

3.2K

H-Index

18

Active since

2000

Affiliations

Agios Pharmaceuticals (United States)(Current)

Howard Hughes Medical Institute

Stanford University

Stanford Synchrotron Radiation Lightsource

Viva Biotech (China)

Byron DeLaBarre is an author at Agios Pharmaceuticals (United States) specializing in life sciences, biochemistry, and molecular biology.

Publications per year

2000–2021

18

Publications

18

Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation

Fang Wang, Jeremy Travins, Byron DeLaBarre et al. · Science · 2013 · 797 citations

, , +10

AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations

Katharine Yen, Jeremy Travins, Fang Wang et al. · Cancer Discovery · 2017 · 458 citations · Full text

, , +17

Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains

Byron DeLaBarre, Axel T. Brünger · Nature Structural & Molecular Biology · 2003 · 385 citations

, , +10

Central Pore Residues Mediate the p97/VCP Activity Required for ERAD

Byron DeLaBarre, John C. Christianson, Ron R. Kopito et al. · Molecular Cell · 2006 · 206 citations · Full text

, , +2

Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle

Isabelle Rouiller, Byron DeLaBarre, Andrew P. May et al. · Nature Structural Biology · 2002 · 204 citations

, , +14

1–5 of 18